Close

Barclays Initiating Coverage: A Seamless Approach to Biopharmaceuticals Dec 9, 2011 01:15PM
Barclays Reiterates an 'Overweight' on Jazz Pharmaceuticals (JAZZ); 2Q Beat/FY10 Raise; Focus on JZP-6 Panel Aug 11, 2010 01:53PM
Notable Analyst Rating Changes 06/15: FINL, JAZZ, AMKR, JCI Upgraded; SMBL, NFLX, ELY, ROSE Downgraded Jun 15, 2010 11:10AM
Jazz Pharmaceuticals (JAZZ) Higher After Positive Analyst Ratings Jun 15, 2010 08:05AM
Barclays Upgrades Jazz Pharmaceuticals (JAZZ) to Overweight Jun 15, 2010 07:41AM


May 11, 2010 09:37AM Jazz Pharma (JAZZ) Prices 7M Common Offering at $8.35/Share
Jun 26, 2009 09:44AM Notable Analyst Rating Changes 6/26: ITW, DB, AAUK Upgraded; JAZZ, OSG, TWB Downgraded
Jun 26, 2009 07:30AM Barclays Downgrades Jazz Pharma (JAZZ) Two-Notches To Underweight
Jun 15, 2009 12:48PM Unusual 11 Mid-Day Movers 6/15: JAZZ, AIM, QEPC, CYCC Higher; ODC, LEA, CDII, IRE Lower